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 Summary
 Background: The aim of this study was an attempt to answer the question whether laser mammography in dense 
breast (classified as category 3,4 according to ACR) examination together with x-ray mammography 
can enhance the detection of breast cancer.
 Material/Method: 248 women who had undergone a CTLM examination and mammography in the Department of 
Radiology of Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology in the 
years 2005–2007 were analyzed retrospectively. In these examinations, x-ray mammography 
did not reveal lesions (BIRADS 1, category 3 and 4 according to ACR). An interval between 
CTLM and mammography did not exceed 30 days. The examination result was verified by 
cytology/histopathology or observation after a minimum of 12 months provided a regular result. 
CTLM visualizes normal and pathological blood vessels and tissues which are rich in blood, because 
laser rays used in CTLM (808nm) are more absorbable by hemoglobin than by the surrounding 
tissue, making it possible to show a malignant tumor by its accompanying angiogenesis. The result 
of CTLM mammography was qualified either as the presence (+) or absence (–) of angiogenesis.
 Results: Among 248 women, angiogenesis was discovered by CTLM in 48 cases, in the CTLM (+) Group 
13/48 women were diagnosed with breast cancer, whereas 35/48 were diagnosed with benign 
lesions.
  Angiogenesis was not identified in 200 women, in the CTLM (-) group 13/200 were diagnosed finally 
with cancer, with 187/200 patients having no malignancy.
  Ultimately, in the group of 248 women (with dense breast, category 3 and 4 according to ACR), 
in whom x-ray mammography did not reveal malignant processes (BIRADS 1), 26 cancers were 
detected out of which 13 were revealed with CTLM
 Conclusions: Computed Tomography Laser Mammography, when used as an adjunct to x-ray mammography, 
enhances the detection of breast cancer in women with dense breast tissue.
 Key words:  CTLM • breast cancer • laser technique • dense breast
 PDF fi le: http://www.polradiol.com/fulltxt.php?ICID=879252
Received: 2008.10.09
Accepted: 2008.12.29
Signature: © Pol J Radiol, 2009; 74(1): 21-24
O R I G I N A L  A R T I C L E
21
Background
Breast cancer is the most common malignant tumor among 
women, accounting for 18.4% of womens' cancers in Poland 
and 22% internationally [1]. Nearly 50% of breast cancer 
cases diagnosed in Poland are advanced stages, with bad 
prognoses [2].
The fundamental method of detecting breast cancer is 
mammography. This method, although having many 
advantages, suffers from two substantial limitations: 
1. ionizing radiation, limiting the possibilities of fre-
quent usage and application in young or pregnant women.
2. problems with cancer visualization in dense breast tissue.
A mammography image depends upon the quantity ratio 
of adipose tissue versus glandular and connective tissues. 
The breast composition is described by a four-degree scale 
introduced by the ACR (American College of Radiology). The 
more adipose tissue (category 1,2 according to ACR) is in the 
breast, the easier it is to visualize cancer infiltration and 
the smaller changes are visible. On the other hand, breast 
composition characterized by high percentage of glandular 
tissue (category 3,4 according to ACR) is associated with sig-
nificant diagnostic problems with location of the pathologic 
foci, which leads to impaired detection of early-stage can-
cer. The mammography symptoms of breast cancer include: 
nodules, microcalcifications, asymmetry, breast architec-
ture distortion The sensitivity of cancer detection in dense 
breasts approximates 75–80% [3–6] In such cases, we regu-
larly apply other available examination modalities such as 
ultrasound and MRI. Ultrasound imaging is a commonly 
used modality, with no known contraindications. Because 
of intensive progress of ultrasonography in the recent years, 
sensitivity increase has been observed and ultrasonography 
can evaluate those areas where masses undetectable by a 
mammogram may occur [7]. Elastosonography is applied 
for evaluation of lesions pictured in presentation B and it 
enhances specificity of ultrasonography [8]. The sensitivity 
of MRI in malignant disease detection ranges from 80 to 
nearly 100% in invasive cancer, but the specificity is much 
lower (37–97%) [9–11]. The cost of the examination, its 
availability but first of all a high number of false positives 
are all limitations of this modality; therefore, it is not rec-
ommended as a routine examination in dense breast cases. 
Taking into account the limitations of currently applied 
modalities, it is reasonable to search for other breast 
imaging techniques. One alternative solution is Computed 
Tomography Laser Mammography (CTLM).This method of 
imaging acquires a 3D breast image by detecting absorption 
of laser light (808 nm wavelength). Laser light of this par-
ticular wavelength is strongly absorbed by the hemoglobin. 
This approach makes it possible to visualize blood vessels: 
healthy, pathologic (angiogenesis) and also areas containing 
blood such as hematomas. A neoplasm, and in particular a 
malignant cancer, stimulates the development of new blood 
vessels (angiogenesis). The vessels developed in neoplastic 
lesions are of irregular build, and generally more numerous 
per unit of volume than in healthy tissue. Because of this, 
a neoplastic lesion and its immediate vicinity contains a 
large amount of hemoglobin – higher than in healthy breast 
tissue [11,12]. The postulate of CTLM is therefore visuali-
sation of angiogenesis accompanying the neoplasm. Laser 
mammography is a safe and non-compressing examination 
using non-ionizing radiation, lending itself to women of all 
ages and to multiple repetitions. Contraindications are rela-
tive and few:
• oozing wounds of the breast,
• less than 3 months following a surgical intervention.
The aim of this study is an attempt to answer the ques-
tion whether the application of laser mammography in 
dense breast (category 3,4 according to ACR) examinations 
in combination with x-ray mammography can enhance the 
detection of breast cancer.
Material and Methods
Material
248 women who had undergone a CTLM examination and 
mammography in the Department of Radiology of Maria 
Sklodowska-Curie Memorial Cancer Center and Institute 
of Oncology in the years 2005–2007 were analyzed retro-
spectively. The criteria for inclusion into the study group 
included:
•  identification of dense breast tissue in x-ray mammogra-
phy -category 3, 4 according to ACR,
• x-ray mammography result BIRADS 1,
•  laser mammography of good quality, without artefacts, 
performed maximum 30 days after the x-ray examination,
•  examination result verified by a cytology/histopathology 
examination or observation – mammography performed 
after a minimum of 12 months provided a regular result.
Method
The CTLM examinations were performed using a CTLM 
device Model 1020 (Imaging Diagnostic Systems, Florida, 
USA) During the examination, the patients were lying prone 
and the scanned breast was positioned loosely in the scan-
ning chamber. The reading of one breast takes around 
10–15 minutes, depending on the breast size. The scanning 
chamber consists of a ring, on the inner circumference of 
which there are two rows of detectors (each row contain-
ing 84 detectors). On the ring there is also a diode emitting 
laser light of 808 nm wavelength. Absorbed light is regis-
tered by the detectors after passing through the imaged 
object. This is the basis for creating axial slices that pic-
ture the absorption of laser light by the tissue present in 
the slice (of 1–4 mm thickness). Subsequently, a 3D image 
is reconstructed. Both bright areas of the CTLM images 
and dark parts were analysed. The former indicated high 
degree of laser light absorption, while the latter indicated 
weak absorption of laser light. For visualization purposes, 
areas appearing dark in CTLM images were considered as 
containing few vessels and/or avascular. Such areas include 
adipose tissue, cysts, fibrous tissue. Areas appearing bright 
in CTLM images were considered as containing many ves-
sels. Such areas can represent glandular tissue, neoplasms, 
inflammation processes.
In a CTLM exam, a blood vessel appears as a bright, linear 
or strand structure. Blood vessels were considered healthy 
if they appeared in a CTLM image as regularly shaped and 
forming a „pyramid” with its base toward the chest wall, 
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and pointed toward the nipple. The presence of angiogen-
esis was defined as an area of amorphic, irregular shape 
and intermediate brightness. The identification of such an 
area was classified as CTLM (+).
The result of CTLM mammography was qualified either as 
the presence (+) or absence (–) of angiogenesis.
All women who had undergone CTLM had also x-ray mam-
mography (in cranio-caudal and oblique projection) at an 
interval not exceeding 30 days.
Results
Among 248 women, angiogenesis was detected by CTLM in 
48 cases (Table 1).
In the CTLM (+) group [48 patients]:
• 13/48 women were diagnosed with breast cancer,
•  35/48 women were diagnosed with benign lesions (in 27 
cases, the diagnosis was established on the basis of core or 
regular biopsy, or a surgical procedure, in the last 8 cases 
the final result was obtained from a control mammogra-
phy performed min. 1 year after the CTLM examination.
Angiogenesis was not identified in 200 women (CTLM (–).
In the CTLM (–) group [200 patients]:
• 13/200 women diagnosed finally with cancer,
•  187/165 women were found clear of malignant disease 
(Table 2).
Ultimately, in the group of 248 women with dense breast (cat-
egory 3 and 4 according to ACR), in whom x-ray mammogra-
phy did not reveal malignant processes (BIRADS 1), 26 cancers 
were detected out of which 13 were revealed with CTLM.
Therefore, the addition of CTLM to x-ray mammography 
increased the detectability of cancer in the examined group 
(category 3,4 according to ACR).
In the examined group, CTLM sensitivity was 50%. 





Table. 1 CTLM and x-ray mammography results.
CTLM + (48/248) CTLM – (200/248)
BIRADS 1 48 200
TP (true positive) 13
FP (false positive) 35
TN (true negative) 187
FN(false negative) 13
Table 2. CTLM results.
Figure 1.  CTLM image – normal breast vessel. No evidence for 
increased laser light absorption – CTLM classifi ed as 
negative.
Figure 2.  CTLM image – area of neovascularization, CTLM classifi ed 
as positive. Histopathologic diagnosis; carcinoma ductal 
invasium.
Figure 3.  CTLM image – area of neovascularization, CTLM classifi ed 
as positive. Histopathologic diagnosis; carcinoma ductal 
invasium.
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Discussion
The aim of this analysis was to check whether the addition 
of CTLM to x-ray mammography would enhance the rate 
of detection of breast cancers in women with dense breast 
tissue.
CTLM is a non-invasive examination with no ionising radi-
ation and no breast compression. The examination can be 
performed many times, irrespective of the patients' age or 
pregnancy. Absolute contraindications to this examination 
are practically not known.
The relevant literature and our experience [13,14] show 
that CTLM does not allow the character of a lesion visible 
in other modalities to be determined. For this reason, we 
have resolved to determine the value of this examination as 
an adjunct for women with dense breast tissue, for whom 
x-ray mammography has limited sensitivity.
According to the authors' knowledge, no work analyzing the 
value of CTLM in cancer diagnosis of dense breast cases has 
been published. We have conducted a retrospective analysis 
of 248 womens' examinations, where x-ray mammography 
did not reveal lesions (BIRADS 1, category 3 and 4 accord-
ing to ACR). All patients underwent a CTLM examination at 
an interval not longer than 30 days since their x-ray scan, 
and the concluding diagnosis was established either on the 
basis of a cyto/histopathological investigation or by obser-
vation. In this group of 248 patients, cancer was ultimately 
diagnosed in 26 women (10.5%), and none of these cancers 
was detectable by x-ray mammography. Laser mammog-
raphy revealed 50% (13/26) of cancers in the group which 
were invisible in mammography examination.
In the examined group, the CTLM sensitivity was 50%, 
specificity 85%, PPV 30%, NPV 90% – these results are 
slightly higher compared to the results we published in 
the previous article [14], (sensitivity 47%, specificity 74%, 
PPV 50%, NP. 72%), and this surely has to do with the 
radiologists' learning curve. The advantage of the method 
is high NPV and specificity [14], a negative examination 
result precludes with a high degree of probability the exis-
tence of a malignant growth process, which may suggest 
the application of this method in prophylactic examina-
tion of young women with a genetic mutation (BRCA 1 
and BRCA 2) [15] There still remains the problem of false 
negative results – the problems with diagnosing angio-
genesis arise when the growth process is localized under 
the nipple (on the account of the subareolar plexus, where 
a physiologically large number of vessels is present in a 
constraint area). In the presented group, 13/26 cases were 
false positives, out of which 2/13 patients had a growth 
process localised under the nipple. In the group of true 
positives there were no growths in that localization. Also 
in the case of rapidly growing tumors with central necro-
sis, angiogenesis may be weakly visible only on the cir-
cumference. There are also problematic artefacts, caused 
mainly by the physical properties of laser light (eg. its 
absorption while penetrating the tissue), in large breasts, 
laser radiation may be absorbed to a very large degree, or 
even completely before it reaches the cancer and/or may 
not reach the detector at all. Unfortunately, angiogenesis 
is not uniquely characteristic of malignant lesions, it may 
also manifest itself in benign lesions such as fibroadeno-
ma, atypical ductal hyperplasia, papilloma and/or foci of 
glandular hyperplasia. In our previously published mate-
rial, angiogenesis in benign cases was present in 100% of 
papillomas, 67% of ductal atypical hyperplasia, 78% of 
inflammations [14].
Conclusions
Computed Tomography Laser Mammography when used as 
an adjunct to x-ray mammography enhances the detection 
of breast cancer in women with dense breast tissue.
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